Acellular pertussis vaccine for adolescents.
出版信息
Paediatr Child Health. 2003 Jul;8(6):378-81. doi: 10.1093/pch/8.6.378.
Abstract
摘要
相似文献
1
Acellular pertussis vaccine for adolescents.
Paediatr Child Health. 2003 Jul;8(6):378-81. doi: 10.1093/pch/8.6.378.
2
Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
J Pediatr. 2006 Nov;149(5):603-610. doi: 10.1016/j.jpeds.2006.06.016.
3
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000.
4
Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic.
Pediatrics. 2015 Jun;135(6):981-9. doi: 10.1542/peds.2014-3358. Epub 2015 May 4.
5
Efficacy of an acellular pertussis vaccine among adolescents and adults.
N Engl J Med. 2005 Oct 13;353(15):1555-63. doi: 10.1056/NEJMoa050824.
6
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15.
7
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Lancet Infect Dis. 2018 Jan;18(1):58-67. doi: 10.1016/S1473-3099(17)30612-6. Epub 2017 Oct 20.
8
Acellular pertussis vaccines: new preparation. Better tolerated but less active?
Prescrire Int. 2000 Feb;9(45):204-7.
9
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pediatrics. 2006 Apr;117(4):1084-93. doi: 10.1542/peds.2005-1759.
10
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults.
Pediatr Infect Dis J. 2000 Apr;19(4):276-83. doi: 10.1097/00006454-200004000-00003.
引用本文的文献
1
A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.
Can J Infect Dis Med Microbiol. 2005 Sep;16(5):271-4. doi: 10.1155/2005/642315.
本文引用的文献
1
Pertussis immunization for adolescents: What are we waiting for?
Paediatr Child Health. 2001 Apr;6(4):184-6. doi: 10.1093/pch/6.4.184.
2
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review.
Clin Infect Dis. 2003 Jan 1;36(1):e1-4. doi: 10.1086/344776. Epub 2002 Dec 16.
3
The changing age and seasonal profile of pertussis in Canada.
J Infect Dis. 2002 May 15;185(10):1448-53. doi: 10.1086/340280. Epub 2002 Apr 22.
4
Morbidity of pertussis in adolescents and adults.
J Infect Dis. 2000 Jul;182(1):174-9. doi: 10.1086/315648. Epub 2000 Jun 30.
5
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults.
Vaccine. 2000 Jan 31;18(14):1312-9. doi: 10.1016/s0264-410x(99)00415-6.
6
Notifiable diseases annual summary. 1992.
Can Commun Dis Rep. 1994 May;20 Suppl 1:1-93.
Zotero 插件